News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,103 Results
Type
Article (86900)
Company Profile (704)
Press Release (765498)
Multimedia
Podcasts (148)
Webinars (19)
Section
Business (232826)
Career Advice (4133)
Deals (39763)
Drug Delivery (130)
Drug Development (91116)
Employer Resources (199)
FDA (18192)
Job Trends (17367)
News (396869)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1574)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (403)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (138)
Biotechnology (482)
Bladder cancer (101)
Brain cancer (41)
Breast cancer (394)
Cancer (3113)
Cardiovascular disease (249)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (577)
Cervical cancer (24)
Clinical research (74345)
Collaboration (1116)
Company closure (3)
Compensation (718)
Complete response letters (34)
COVID-19 (2906)
CRISPR (68)
C-suite (362)
Cystic fibrosis (122)
Data (3112)
Decentralized trials (2)
Denatured (52)
Depression (78)
Diabetes (380)
Diagnostics (6982)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (184)
Drug pricing (153)
Drug shortages (36)
Duchenne muscular dystrophy (139)
Earnings (97549)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131492)
Executive appointments (911)
FDA (19951)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1020)
Gene editing (149)
Generative AI (40)
Gene therapy (440)
GLP-1 (937)
Government (5265)
Grass and pollen (6)
Guidances (183)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3104)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (72)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (58)
Layoffs (595)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (216)
Machine learning (12)
Management (65)
Manufacturing (449)
MASH (100)
Medical device (14734)
Medtech (14740)
Mergers & acquisitions (22587)
Metabolic disorders (969)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (146)
Neuropsychiatric disorders (43)
Neuroscience (2336)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (128)
Parkinson's disease (201)
Partnered (25)
Patents (323)
Patient recruitment (175)
Peanut (55)
People (65738)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22946)
Phase II (32280)
Phase III (24307)
Pipeline (1712)
Policy (246)
Postmarket research (3552)
Preclinical (10363)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (530)
Real estate (7402)
Recruiting (76)
Regulatory (27193)
Reports (62)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (99)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (66)
The Weekly (94)
Vaccines (920)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (72)
Last 7 days (396)
Last 30 days (1973)
Last 365 days (33952)
2025 (18642)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50549)
Australia (8880)
California (7820)
Canada (2423)
China (728)
Colorado (340)
Connecticut (349)
Delaware (205)
Europe (115969)
Florida (1163)
Georgia (266)
Hawaii (2)
Idaho (66)
Illinois (747)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1109)
Massachusetts (5992)
Michigan (276)
Minnesota (489)
Mississippi (3)
Missouri (103)
Montana (32)
Nebraska (26)
Nevada (84)
New Hampshire (73)
New Jersey (2199)
New Mexico (31)
New York (2194)
North Carolina (1250)
North Dakota (10)
Northern California (3368)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1670)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2901)
Tennessee (130)
Texas (1202)
United States (29558)
Utah (231)
Virginia (216)
Washington D.C. (80)
Washington State (693)
West Virginia (4)
Wisconsin (86)
There are 853,103 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
July 18, 2025
·
160 min read
·
BioSpace Editorial Staff
Press Releases
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
July 18, 2025
·
1 min read
Press Releases
Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease
July 18, 2025
·
6 min read
Press Releases
Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)
July 18, 2025
·
10 min read
Press Releases
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
July 18, 2025
·
5 min read
Press Releases
Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)
July 18, 2025
·
4 min read
Press Releases
Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia
July 18, 2025
·
13 min read
Clinical research
BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial
Despite the failure, BMS remains “encouraged” by Reblozyl’s clinical activity in myelofibrosis-associated anemia and will approach regulators to discuss potential submissions for this indication, for which few treatment options exist.
July 18, 2025
·
2 min read
·
Tristan Manalac
Cancer
GSK’s Blenrep Loses Adcomm Vote, Further Clouding Comeback Bid
The panelists flagged safety concerns with Blenrep and GSK’s failure to optimize its dosing regimen for the antibody-drug conjugate in multiple myeloma.
July 18, 2025
·
2 min read
·
Tristan Manalac
Duchenne muscular dystrophy
Sarepta Reports a Third Gene-Therapy Related Patient Death
The patient, who was being treated with an investigational gene therapy for limb-girdle muscular dystrophy, died of acute liver failure, the same complication responsible for the deaths of two boys taking Sarepta’s Duchenne muscular dystrophy treatment Elevidys.
July 18, 2025
·
2 min read
·
Tristan Manalac
1 of 85,311
Next
